Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017
Jennifer F. De Los Santos, Alan Cantor, Keith D. Amos, Andres Forero, Mehra Golshan, Janet K. Horton, Clifford A. Hudis, Nola M. Hylton, Kandace McGuire, Funda Meric-Bernstam, Ingrid M. Meszoely, Rita Nanda, E. Shelley Hwang
Dive into the research topics of 'Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017'. Together they form a unique fingerprint.